Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

NCT04971785 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

457

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Steatohepatitis

Interventions

DRUG: Semaglutide (SEMA)
DRUG: Cilofexor (CILO)/Firsocostat (FIR)
DRUG: PTM SEMA
DRUG: PTM CILO/FIR

Sponsor

Gilead Sciences

Collaborators

[object Object]